Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells
about
MicroRNA-146a decreases high glucose/thrombin-induced endothelial inflammation by inhibiting NAPDH oxidase 4 expressionNox2 mediates skeletal muscle insulin resistance induced by a high fat dietAngiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4.The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular systemCalcineurin Aβ regulates NADPH oxidase (Nox) expression and activity via nuclear factor of activated T cells (NFAT) in response to high glucose.Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium.Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling.NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis.Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress.Functional Role of Nox4 in Autophagy.NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.NADPH oxidase 4 mediates ROS production in radiation-induced senescent cells and promotes migration of inflammatory cells.Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes.Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.
P2860
Q34266384-735A59CA-B174-479F-B13F-27CE319CABABQ35861004-17A388B4-5872-4B7A-96EC-B267EB73E48BQ36312399-AD39D521-E3A9-466F-BB84-D9A63AFEA083Q36561549-EDE61FB1-119B-4083-AF0A-E2920E3D67B4Q36711861-89004EC9-28E7-47F4-869B-87007E239DC1Q36952106-7FF4FF62-1D9F-4A27-B290-55C20395E4D4Q37596337-B809E80F-5721-4453-A4F4-8B44BCD97EECQ38622980-4E190836-0F68-4002-B6AA-B31B68F18649Q39039959-FDD5D66A-DABE-4779-8CFE-BC09990764FFQ39093815-BA170409-78D2-4659-BB99-A46E530BACC9Q39144504-0A59AA60-45AD-4BDF-8EB4-4B16C57CA690Q39334544-9D884981-B88D-4907-86ED-6965FD4A66BFQ43232684-4D8A6FDA-44A6-461E-A97E-EFEEA99A455EQ46243640-20FBD713-8228-4654-A787-232F9BFC0DC0Q46426649-DC80B6B8-31D4-414B-B793-81C605EDC8ECQ46797946-CDF65DD0-BC67-4891-93F7-94BD45DB2601Q47779172-26AC8F8C-E471-4E2E-8AEF-2D639D5AE264Q50224206-F1098C9C-85C7-4177-954C-E802B97C53A0
P2860
Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@ast
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@en
type
label
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@ast
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@en
prefLabel
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@ast
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@en
P2093
P2860
P921
P1476
Rosiglitazone attenuates NF-κB ...... ia-activated endothelial cells
@en
P2093
C Michael Hart
Clintoria R Williams
Roy L Sutliff
Xianghuai Lu
P2860
P304
P356
10.1152/AJPCELL.00227.2011
P577
2012-05-09T00:00:00Z